Literature DB >> 28137726

Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Michael J Boland1,2, Kristopher L Nazor1,2, Ha T Tran1,2, Attila Szücs3,4, Candace L Lynch1,2, Ryder Paredes5, Flora Tassone6,7, Pietro Paolo Sanna8, Randi J Hagerman7,9, Jeanne F Loring1,2.   

Abstract

New research suggests that common pathways are altered in many neurodevelopmental disorders including autism spectrum disorder; however, little is known about early molecular events that contribute to the pathology of these diseases. The study of monogenic, neurodevelopmental disorders with a high incidence of autistic behaviours, such as fragile X syndrome, has the potential to identify genes and pathways that are dysregulated in autism spectrum disorder as well as fragile X syndrome. In vitro generation of human disease-relevant cell types provides the ability to investigate aspects of disease that are impossible to study in patients or animal models. Differentiation of human pluripotent stem cells recapitulates development of the neocortex, an area affected in both fragile X syndrome and autism spectrum disorder. We have generated induced human pluripotent stem cells from several individuals clinically diagnosed with fragile X syndrome and autism spectrum disorder. When differentiated to dorsal forebrain cell fates, our fragile X syndrome human pluripotent stem cell lines exhibited reproducible aberrant neurogenic phenotypes. Using global gene expression and DNA methylation profiling, we have analysed the early stages of neurogenesis in fragile X syndrome human pluripotent stem cells. We discovered aberrant DNA methylation patterns at specific genomic regions in fragile X syndrome cells, and identified dysregulated gene- and network-level correlates of fragile X syndrome that are associated with developmental signalling, cell migration, and neuronal maturation. Integration of our gene expression and epigenetic analysis identified altered epigenetic-mediated transcriptional regulation of a distinct set of genes in fragile X syndrome. These fragile X syndrome-aberrant networks are significantly enriched for genes associated with autism spectrum disorder, giving support to the idea that underlying similarities exist among these neurodevelopmental diseases.
© The Author (2017). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  autism spectrum disorder; brain development; fragile X syndrome; neurogenesis; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28137726      PMCID: PMC5837342          DOI: 10.1093/brain/aww357

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  50 in total

1.  FMRP regulates the transition from radial glial cells to intermediate progenitor cells during neocortical development.

Authors:  Roya Saffary; Zhigang Xie
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses.

Authors:  Laura N Antar; Chanxia Li; Honglai Zhang; Reed C Carroll; Gary J Bassell
Journal:  Mol Cell Neurosci       Date:  2006-05-02       Impact factor: 4.314

3.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

4.  Altered synaptic plasticity in a mouse model of fragile X mental retardation.

Authors:  Kimberly M Huber; Sean M Gallagher; Stephen T Warren; Mark F Bear
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

5.  Altered differentiation of neural stem cells in fragile X syndrome.

Authors:  Maija Castrén; Topi Tervonen; Virve Kärkkäinen; Seppo Heinonen; Eero Castrén; Kim Larsson; Cathy E Bakker; Ben A Oostra; Karl Akerman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

6.  A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Authors:  Johannes Fritzmann; Markus Morkel; Daniel Besser; Jan Budczies; Frauke Kosel; Felix H Brembeck; Ulrike Stein; Iduna Fichtner; Peter M Schlag; Walter Birchmeier
Journal:  Gastroenterology       Date:  2009-03-26       Impact factor: 22.682

7.  Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.

Authors:  Chul-Yong Park; Tomer Halevy; Dongjin R Lee; Jin Jea Sung; Jae Souk Lee; Ofra Yanuka; Nissim Benvenisty; Dong-Wook Kim
Journal:  Cell Rep       Date:  2015-10-01       Impact factor: 9.423

8.  FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.

Authors:  Jennifer C Darnell; Sarah J Van Driesche; Chaolin Zhang; Ka Ying Sharon Hung; Aldo Mele; Claire E Fraser; Elizabeth F Stone; Cynthia Chen; John J Fak; Sung Wook Chi; Donny D Licatalosi; Joel D Richter; Robert B Darnell
Journal:  Cell       Date:  2011-07-22       Impact factor: 41.582

9.  Fragile x syndrome.

Authors:  Yingratana McLennan; Jonathan Polussa; Flora Tassone; Randi Hagerman
Journal:  Curr Genomics       Date:  2011-05       Impact factor: 2.236

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  29 in total

Review 1.  Multifarious Functions of the Fragile X Mental Retardation Protein.

Authors:  Jenna K Davis; Kendal Broadie
Journal:  Trends Genet       Date:  2017-08-18       Impact factor: 11.639

Review 2.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

3.  Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing.

Authors:  Pay Giesselmann; Björn Brändl; Etienne Raimondeau; Rebecca Bowen; Christian Rohrandt; Rashmi Tandon; Helene Kretzmer; Günter Assum; Christina Galonska; Reiner Siebert; Ole Ammerpohl; Andrew Heron; Susanne A Schneider; Julia Ladewig; Philipp Koch; Bernhard M Schuldt; James E Graham; Alexander Meissner; Franz-Josef Müller
Journal:  Nat Biotechnol       Date:  2019-11-18       Impact factor: 54.908

Review 4.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

5.  Cell-type-specific profiling of human cellular models of fragile X syndrome reveal PI3K-dependent defects in translation and neurogenesis.

Authors:  Nisha Raj; Zachary T McEachin; William Harousseau; Ying Zhou; Feiran Zhang; Megan E Merritt-Garza; J Matthew Taliaferro; Magdalena Kalinowska; Samuele G Marro; Chadwick M Hales; Elizabeth Berry-Kravis; Marisol W Wolf-Ochoa; Veronica Martinez-Cerdeño; Marius Wernig; Lu Chen; Eric Klann; Stephen T Warren; Peng Jin; Zhexing Wen; Gary J Bassell
Journal:  Cell Rep       Date:  2021-04-13       Impact factor: 9.423

6.  Maturation Delay of Human GABAergic Neurogenesis in Fragile X Syndrome Pluripotent Stem Cells.

Authors:  Ai Zhang; Irina Sokolova; Alain Domissy; Joshua Davis; Lee Rao; Kagistia Hana Utami; Yanling Wang; Randi J Hagerman; Mahmoud A Pouladi; Pietro Sanna; Michael J Boland; Jeanne F Loring
Journal:  Stem Cells Transl Med       Date:  2022-06-22       Impact factor: 7.655

7.  Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism.

Authors:  J Nagy; J Kobolák; S Berzsenyi; Z Ábrahám; H X Avci; I Bock; Z Bekes; B Hodoscsek; A Chandrasekaran; A Téglási; P Dezső; B Koványi; E T Vörös; L Fodor; T Szél; K Németh; A Balázs; A Dinnyés; B Lendvai; G Lévay; V Román
Journal:  Transl Psychiatry       Date:  2017-07-25       Impact factor: 6.222

Review 8.  Editing the genome of hiPSC with CRISPR/Cas9: disease models.

Authors:  Andrew R Bassett
Journal:  Mamm Genome       Date:  2017-03-16       Impact factor: 2.957

9.  THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders.

Authors:  Boris Guennewig; Maina Bitar; Ifeanyi Obiorah; James Hanks; Elizabeth A O'Brien; Dominik C Kaczorowski; Yasmin L Hurd; Panos Roussos; Kristen J Brennand; Guy Barry
Journal:  Transl Psychiatry       Date:  2018-04-25       Impact factor: 7.989

10.  Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells.

Authors:  Naohiro Sunamura; Shinzo Iwashita; Kei Enomoto; Taisuke Kadoshima; Fujio Isono
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.